Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell neoplasms: an overview.

Sebastien Kairouz1, Jana Hashash, Wadih Kabbara

  • 1Department of Internal Medicine, Division of Hematology/Oncology, The George Washington University Medical Center, Washington, DC 20037, USA.

American Journal of Hematology
|July 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Cancer investigation·2026
Same author

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

The New England journal of medicine·2026
Same author

Targeted Therapies in Non-Small Cell Lung Cancer: A Contemporary Review.

American journal of clinical oncology·2025
Same author

Perioperative Drug Management of Systemic Therapies in Breast Cancer: A Literature Review and Treatment Recommendations.

Current oncology (Toronto, Ont.)·2025
Same author

Bruton Tyrosine Kinase Degraders: Current Concepts.

American journal of clinical oncology·2025
Same author

Maintenance Therapy in Acute Myeloid Leukemia.

American journal of clinical oncology·2024
Same journal

EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.

American journal of hematology·2026
Same journal

Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count.

American journal of hematology·2026
Same journal

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1.

American journal of hematology·2026
Same journal

Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma.

American journal of hematology·2026
Same journal

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

American journal of hematology·2026
Same journal

Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk-Stratification and Management.

American journal of hematology·2026
See all related articles

Dendritic cell neoplasms, rare tumors previously misclassified, are increasingly recognized. This overview details pathological, clinical, and therapeutic aspects of specific types like follicular dendritic cell tumors.

Area of Science:

  • Oncology
  • Pathology
  • Immunology

Background:

  • Dendritic cell neoplasms are rare tumors with increasing recognition.
  • Previously classified under lymphomas, sarcomas, or histiocytic neoplasms.
  • The World Health Organization (WHO) established a classification system for these neoplasms.

Purpose of the Study:

  • To provide a concise overview of dendritic cell neoplasms.
  • To focus on pathological, clinical, and therapeutic aspects.
  • To cover Langerhans' cell tumors, interdigitating dendritic cell tumors, and follicular dendritic cell tumors.

Main Methods:

  • Review of existing literature and classifications.
  • Synthesis of information on pathological features.
  • Compilation of clinical and therapeutic data.

Related Experiment Videos

Main Results:

  • Dendritic cell neoplasms encompass five WHO-defined groups.
  • Recent immunohistochemical classifications offer further distinctions.
  • Specific focus on Langerhans', interdigitating dendritic, and follicular dendritic cell tumors.

Conclusions:

  • Understanding dendritic cell neoplasms requires knowledge of their evolving classification.
  • Pathological, clinical, and therapeutic insights are crucial for patient management.
  • This review consolidates key information on specific dendritic cell tumor types.